aluates Reports

$ 0.0

Automative

Global Metastatic Colorectal Cancer Treatment Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-8F4291

Global Metastatic Colorectal Cancer Treatment Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Metastatic Colorectal Cancer Treatment Market Research Report 2024

Code: QYRE-Auto-8F4291

Report

January 2024

Pages:84

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sanofi

Roche

Eli Lilly

Pfizer Inc

Novartis

Amgen Inc

Taiho Oncology

EMD Serono

Suzhou Zelgen Biopharmaceuticals

Genentech Inc

Metastatic Colorectal Cancer Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Metastatic Colorectal Cancer Treatment Market

Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body parts i.e. metastatic colorectal cancers are difficult to treat and have 11%-12% 5-year relative survival rate.

The global Metastatic Colorectal Cancer Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Metastatic Colorectal Cancer Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metastatic Colorectal Cancer Treatment.

Report Scope

The Metastatic Colorectal Cancer Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Metastatic Colorectal Cancer Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Metastatic Colorectal Cancer Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Metastatic Colorectal Cancer Treatment Market Report

Report Metric	Details
Report Name	Metastatic Colorectal Cancer Treatment Market
CAGR	5%
Segment by Type	Surgery Chemotherapy
Segment by Application	Hospitals Clinics Cancer Research Centers
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, Roche, Eli Lilly, Pfizer, Novartis, Amgen, Taiho Oncology, Genentech, EMD Serono, Suzhou Zelgen Biopharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Metastatic Colorectal Cancer Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Metastatic Colorectal Cancer Treatment Market report?

Ans: The main players in the Metastatic Colorectal Cancer Treatment Market are Sanofi, Roche, Eli Lilly, Pfizer, Novartis, Amgen, Taiho Oncology, Genentech, EMD Serono, Suzhou Zelgen Biopharmaceuticals

What are the Application segmentation covered in the Metastatic Colorectal Cancer Treatment Market report?

Ans: The Applications covered in the Metastatic Colorectal Cancer Treatment Market report are Hospitals, Clinics, Cancer Research Centers

What are the Type segmentation covered in the Metastatic Colorectal Cancer Treatment Market report?

Ans: The Types covered in the Metastatic Colorectal Cancer Treatment Market report are Surgery, Chemotherapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Metastatic Colorectal Cancer Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Surgery

1.2.3 Chemotherapy

1.3 Market by Application

1.3.1 Global Metastatic Colorectal Cancer Treatment Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Cancer Research Centers

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Metastatic Colorectal Cancer Treatment Market Perspective (2019-2030)

2.2 Metastatic Colorectal Cancer Treatment Growth Trends by Region

2.2.1 Global Metastatic Colorectal Cancer Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Metastatic Colorectal Cancer Treatment Historic Market Size by Region (2019-2024)

2.2.3 Metastatic Colorectal Cancer Treatment Forecasted Market Size by Region (2025-2030)

2.3 Metastatic Colorectal Cancer Treatment Market Dynamics

2.3.1 Metastatic Colorectal Cancer Treatment Industry Trends

2.3.2 Metastatic Colorectal Cancer Treatment Market Drivers

2.3.3 Metastatic Colorectal Cancer Treatment Market Challenges

2.3.4 Metastatic Colorectal Cancer Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Metastatic Colorectal Cancer Treatment Players by Revenue

3.1.1 Global Top Metastatic Colorectal Cancer Treatment Players by Revenue (2019-2024)

3.1.2 Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Metastatic Colorectal Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Metastatic Colorectal Cancer Treatment Revenue

3.4 Global Metastatic Colorectal Cancer Treatment Market Concentration Ratio

3.4.1 Global Metastatic Colorectal Cancer Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Metastatic Colorectal Cancer Treatment Revenue in 2023

3.5 Metastatic Colorectal Cancer Treatment Key Players Head office and Area Served

3.6 Key Players Metastatic Colorectal Cancer Treatment Product Solution and Service

3.7 Date of Enter into Metastatic Colorectal Cancer Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Metastatic Colorectal Cancer Treatment Breakdown Data by Type

4.1 Global Metastatic Colorectal Cancer Treatment Historic Market Size by Type (2019-2024)

4.2 Global Metastatic Colorectal Cancer Treatment Forecasted Market Size by Type (2025-2030)

5 Metastatic Colorectal Cancer Treatment Breakdown Data by Application

5.1 Global Metastatic Colorectal Cancer Treatment Historic Market Size by Application (2019-2024)

5.2 Global Metastatic Colorectal Cancer Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Metastatic Colorectal Cancer Treatment Market Size (2019-2030)

6.2 North America Metastatic Colorectal Cancer Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Metastatic Colorectal Cancer Treatment Market Size by Country (2019-2024)

6.4 North America Metastatic Colorectal Cancer Treatment Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Metastatic Colorectal Cancer Treatment Market Size (2019-2030)

7.2 Europe Metastatic Colorectal Cancer Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Metastatic Colorectal Cancer Treatment Market Size by Country (2019-2024)

7.4 Europe Metastatic Colorectal Cancer Treatment Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size (2019-2030)

8.2 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Region (2019-2024)

8.4 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Metastatic Colorectal Cancer Treatment Market Size (2019-2030)

9.2 Latin America Metastatic Colorectal Cancer Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Metastatic Colorectal Cancer Treatment Market Size by Country (2019-2024)

9.4 Latin America Metastatic Colorectal Cancer Treatment Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size (2019-2030)

10.2 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Country (2019-2024)

10.4 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sanofi

11.1.1 Sanofi Company Detail

11.1.2 Sanofi Business Overview

11.1.3 Sanofi Metastatic Colorectal Cancer Treatment Introduction

11.1.4 Sanofi Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024)

11.1.5 Sanofi Recent Development

11.2 Roche

11.2.1 Roche Company Detail

11.2.2 Roche Business Overview

11.2.3 Roche Metastatic Colorectal Cancer Treatment Introduction

11.2.4 Roche Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024)

11.2.5 Roche Recent Development

11.3 Eli Lilly

11.3.1 Eli Lilly Company Detail

11.3.2 Eli Lilly Business Overview

11.3.3 Eli Lilly Metastatic Colorectal Cancer Treatment Introduction

11.3.4 Eli Lilly Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024)

11.3.5 Eli Lilly Recent Development

11.4 Pfizer

11.4.1 Pfizer Company Detail

11.4.2 Pfizer Business Overview

11.4.3 Pfizer Metastatic Colorectal Cancer Treatment Introduction

11.4.4 Pfizer Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024)

11.4.5 Pfizer Recent Development

11.5 Novartis

11.5.1 Novartis Company Detail

11.5.2 Novartis Business Overview

11.5.3 Novartis Metastatic Colorectal Cancer Treatment Introduction

11.5.4 Novartis Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024)

11.5.5 Novartis Recent Development

11.6 Amgen

11.6.1 Amgen Company Detail

11.6.2 Amgen Business Overview

11.6.3 Amgen Metastatic Colorectal Cancer Treatment Introduction

11.6.4 Amgen Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024)

11.6.5 Amgen Recent Development

11.7 Taiho Oncology

11.7.1 Taiho Oncology Company Detail

11.7.2 Taiho Oncology Business Overview

11.7.3 Taiho Oncology Metastatic Colorectal Cancer Treatment Introduction

11.7.4 Taiho Oncology Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024)

11.7.5 Taiho Oncology Recent Development

11.8 Genentech

11.8.1 Genentech Company Detail

11.8.2 Genentech Business Overview

11.8.3 Genentech Metastatic Colorectal Cancer Treatment Introduction

11.8.4 Genentech Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024)

11.8.5 Genentech Recent Development

11.9 EMD Serono

11.9.1 EMD Serono Company Detail

11.9.2 EMD Serono Business Overview

11.9.3 EMD Serono Metastatic Colorectal Cancer Treatment Introduction

11.9.4 EMD Serono Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024)

11.9.5 EMD Serono Recent Development

11.10 Suzhou Zelgen Biopharmaceuticals

11.10.1 Suzhou Zelgen Biopharmaceuticals Company Detail

11.10.2 Suzhou Zelgen Biopharmaceuticals Business Overview

11.10.3 Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Treatment Introduction

11.10.4 Suzhou Zelgen Biopharmaceuticals Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024)

11.10.5 Suzhou Zelgen Biopharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Sanofi

Roche

Eli Lilly

Pfizer Inc

Novartis

Amgen Inc

Taiho Oncology

EMD Serono

Suzhou Zelgen Biopharmaceuticals

Genentech Inc

List of Tables

Table 1. Global Metastatic Colorectal Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Surgery

Table 3. Key Players of Chemotherapy

Table 4. Global Metastatic Colorectal Cancer Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Metastatic Colorectal Cancer Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Metastatic Colorectal Cancer Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Metastatic Colorectal Cancer Treatment Market Share by Region (2019-2024)

Table 8. Global Metastatic Colorectal Cancer Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Metastatic Colorectal Cancer Treatment Market Share by Region (2025-2030)

Table 10. Metastatic Colorectal Cancer Treatment Market Trends

Table 11. Metastatic Colorectal Cancer Treatment Market Drivers

Table 12. Metastatic Colorectal Cancer Treatment Market Challenges

Table 13. Metastatic Colorectal Cancer Treatment Market Restraints

Table 14. Global Metastatic Colorectal Cancer Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Metastatic Colorectal Cancer Treatment Market Share by Players (2019-2024)

Table 16. Global Top Metastatic Colorectal Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metastatic Colorectal Cancer Treatment as of 2023)

Table 17. Ranking of Global Top Metastatic Colorectal Cancer Treatment Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Metastatic Colorectal Cancer Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Metastatic Colorectal Cancer Treatment Product Solution and Service

Table 21. Date of Enter into Metastatic Colorectal Cancer Treatment Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Metastatic Colorectal Cancer Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Type (2019-2024)

Table 25. Global Metastatic Colorectal Cancer Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Type (2025-2030)

Table 27. Global Metastatic Colorectal Cancer Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Application (2019-2024)

Table 29. Global Metastatic Colorectal Cancer Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Application (2025-2030)

Table 31. North America Metastatic Colorectal Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Metastatic Colorectal Cancer Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Metastatic Colorectal Cancer Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Metastatic Colorectal Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Metastatic Colorectal Cancer Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Metastatic Colorectal Cancer Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Metastatic Colorectal Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Metastatic Colorectal Cancer Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Metastatic Colorectal Cancer Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 46. Sanofi Company Detail

Table 47. Sanofi Business Overview

Table 48. Sanofi Metastatic Colorectal Cancer Treatment Product

Table 49. Sanofi Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024) & (US$ Million)

Table 50. Sanofi Recent Development

Table 51. Roche Company Detail

Table 52. Roche Business Overview

Table 53. Roche Metastatic Colorectal Cancer Treatment Product

Table 54. Roche Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024) & (US$ Million)

Table 55. Roche Recent Development

Table 56. Eli Lilly Company Detail

Table 57. Eli Lilly Business Overview

Table 58. Eli Lilly Metastatic Colorectal Cancer Treatment Product

Table 59. Eli Lilly Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024) & (US$ Million)

Table 60. Eli Lilly Recent Development

Table 61. Pfizer Company Detail

Table 62. Pfizer Business Overview

Table 63. Pfizer Metastatic Colorectal Cancer Treatment Product

Table 64. Pfizer Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024) & (US$ Million)

Table 65. Pfizer Recent Development

Table 66. Novartis Company Detail

Table 67. Novartis Business Overview

Table 68. Novartis Metastatic Colorectal Cancer Treatment Product

Table 69. Novartis Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024) & (US$ Million)

Table 70. Novartis Recent Development

Table 71. Amgen Company Detail

Table 72. Amgen Business Overview

Table 73. Amgen Metastatic Colorectal Cancer Treatment Product

Table 74. Amgen Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024) & (US$ Million)

Table 75. Amgen Recent Development

Table 76. Taiho Oncology Company Detail

Table 77. Taiho Oncology Business Overview

Table 78. Taiho Oncology Metastatic Colorectal Cancer Treatment Product

Table 79. Taiho Oncology Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024) & (US$ Million)

Table 80. Taiho Oncology Recent Development

Table 81. Genentech Company Detail

Table 82. Genentech Business Overview

Table 83. Genentech Metastatic Colorectal Cancer Treatment Product

Table 84. Genentech Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024) & (US$ Million)

Table 85. Genentech Recent Development

Table 86. EMD Serono Company Detail

Table 87. EMD Serono Business Overview

Table 88. EMD Serono Metastatic Colorectal Cancer Treatment Product

Table 89. EMD Serono Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024) & (US$ Million)

Table 90. EMD Serono Recent Development

Table 91. Suzhou Zelgen Biopharmaceuticals Company Detail

Table 92. Suzhou Zelgen Biopharmaceuticals Business Overview

Table 93. Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Treatment Product

Table 94. Suzhou Zelgen Biopharmaceuticals Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024) & (US$ Million)

Table 95. Suzhou Zelgen Biopharmaceuticals Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Metastatic Colorectal Cancer Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Metastatic Colorectal Cancer Treatment Market Share by Type: 2023 VS 2030

Figure 3. Surgery Features

Figure 4. Chemotherapy Features

Figure 5. Global Metastatic Colorectal Cancer Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Metastatic Colorectal Cancer Treatment Market Share by Application: 2023 VS 2030

Figure 7. Hospitals Case Studies

Figure 8. Clinics Case Studies

Figure 9. Cancer Research Centers Case Studies

Figure 10. Metastatic Colorectal Cancer Treatment Report Years Considered

Figure 11. Global Metastatic Colorectal Cancer Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Metastatic Colorectal Cancer Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Metastatic Colorectal Cancer Treatment Market Share by Region: 2023 VS 2030

Figure 14. Global Metastatic Colorectal Cancer Treatment Market Share by Players in 2023

Figure 15. Global Top Metastatic Colorectal Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metastatic Colorectal Cancer Treatment as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Metastatic Colorectal Cancer Treatment Revenue in 2023

Figure 17. North America Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Metastatic Colorectal Cancer Treatment Market Share by Country (2019-2030)

Figure 19. United States Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Metastatic Colorectal Cancer Treatment Market Share by Country (2019-2030)

Figure 23. Germany Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Share by Region (2019-2030)

Figure 31. China Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Metastatic Colorectal Cancer Treatment Market Share by Country (2019-2030)

Figure 39. Mexico Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Share by Country (2019-2030)

Figure 43. Turkey Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Sanofi Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2019-2024)

Figure 46. Roche Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2019-2024)

Figure 47. Eli Lilly Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2019-2024)

Figure 48. Pfizer Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2019-2024)

Figure 49. Novartis Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2019-2024)

Figure 50. Amgen Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2019-2024)

Figure 51. Taiho Oncology Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2019-2024)

Figure 52. Genentech Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2019-2024)

Figure 53. EMD Serono Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2019-2024)

Figure 54. Suzhou Zelgen Biopharmaceuticals Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2019-2024)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pediatric Cardiac Tumor Diagnostic Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-6G6046

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Interventional Oncology Device Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-20U7613

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Colon Cancer Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-31C5944

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global CAR T-Cell Immunotherapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-10J13802

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions